ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
2026-04-08
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
2026-04-07
$79.71
+0.7 ( 0.89% )
Pricing delayed by 20 minutes
Last updated
2026-04-09 14:16:00